With something like this, how would one go about trying to sign up for more trails or early adoption blah blah?
this post was submitted on 24 Jun 2024
31 points (97.0% liked)
Neuroscience
43 readers
1 users here now
Discussions about the science of the brain
founded 4 months ago
MODERATORS
Where trials will be run and eligibility will depend on industry/clinical partners. Unsure what the in/exclusion criteria will be as it seems to be better for early stages and alzheimers isn't the easiest disease to catch early. They may also want to do an NHP (non-human primate) trial before going to humans depending on what side-effects they saw in the mice and weren't mentioned in this news article.